Text Size
1 study found for:    NCT01208766

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Recruiting Study to Compare VMP With HDM Followed by VRD Consolidation and Lenalidomide Maintenance in Patients With Newly Diagnosed Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: Bortezomib, Melphalan, Prednisone (VMP);   Drug: 1 or 2 cycle(s) HDM (High Dose Melphalan);   Drug: 2 cycles of Bortezomib, Lenalidomide, Dexamethasone (VRD)
To Top

† Indicates status has not been verified in more than two years